One of the main challenges is ensuring that their contributions lead to tangible outcomes. There is also the risk of public skepticism, where the motives of corporate sponsorship may be questioned. Companies need to be transparent about their goals and outcomes to build trust. Additionally, aligning corporate goals with the needs of the cancer community can sometimes be complex, requiring careful planning and collaboration.
